Mucormycosis, renowned as black fungus, is an uncommon and invasive fungal infection that commonly targets immunocompromised patients

dc.contributor.authorArora, N.
dc.contributor.authorKakde, A.
dc.contributor.authorPandey, G.
dc.contributor.authorNaaz, H.
dc.contributor.authorGoyal, L.
dc.contributor.authorTiwari, S.
dc.contributor.authorElngar, A.A.
dc.date.accessioned2026-02-08T16:49:50Z
dc.date.issued2024
dc.description.abstractA group of molds called Mucor causes mucormycosis. According to the Centre for Disease Control and Prevention (CDC), this type of infection has a mortality rate of 46%. According to a survey, mucormycosis has affected only 109 thousand people in India annually in the past which is 1% of the total population. But recently, the cases are increasing at a very high pace. It's presumed that uncontrolled diabetes and careless use of steroids are two main factors for the spread of mucormycosis in India. This fungus spread through the paranasal sinus into orbit affecting, the eyes,brain, and lungs. Therefore, it is vital to diagnose mucormycosis at the right point in time for timely treatment. Hence, this paper provides insight into mucormycosis occurrence in diabetic and COVID-19 patients and covers the types of disease (mucormycosis/COVID-19), and investigates how these molds are getting a chance to invade the body of immunocompromised patients. In addition, this paper addresses possible treatments and preventive measures © 2025 Apple Academic Press, Inc. All rights reserved.
dc.identifier.citationGlobal Digital Transformation and the COVID-19 Pandemic, 2024, Vol., , p. 171-188
dc.identifier.isbn9781003857167
dc.identifier.isbn9781774915509
dc.identifier.urihttps://doi.org/10.1007/978-981-95-3754-9_21
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/33513
dc.publisherApple Academic Press
dc.titleMucormycosis, renowned as black fungus, is an uncommon and invasive fungal infection that commonly targets immunocompromised patients

Files

Collections